Načítá se...
SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department
BACKGROUND: In the emergency department (ED) setting, rapid testing for SARS-CoV-2 is likely associated with advantages to patients and healthcare workers, for example, enabling early but rationale use of limited isolation resources. Most recently, several SARS-CoV-2 rapid point-of-care antigen test...
Uloženo v:
| Vydáno v: | Biomarkers |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7898296/ https://ncbi.nlm.nih.gov/pubmed/33455451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1354750X.2021.1876769 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|